The patient's history was positive for two infarcts and cardiogenic shock at the time a ventricular septal defect closure (vsd) was scheduled.In the medical opinion of the physician, vsd occluders were not suitable and the physician opted to use a 38mm amplatzer septal occluder (aso).At the time of implant, the aso prolapsed into the right ventricle as it was too small for the defect.During the procedure, the patient experienced ventricular tachycardia and required multiple defibrillations and the procedure was aborted.The patient was stabilized.
|
The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The 38mm aso was returned to sjm and decontaminated.The occluder was grossly and microscopically examined, and no anomalies were found.It met dimensional specifications when measured with a caliper.The aso was loaded into a test loader, deployed and retracted without difficulty or deformation, under non-physiological conditions.The results of this investigation confirmed the aso met all functional and dimensional specifications when analyzed at sjm.There was no evidence to suggest there was an intrinsic defect in the occluder, and the cause of the reported prolapse remains unknown.
|